Jayne Gershkowitz, VP, Patient Advocacy at AMICUS THERAPEUTICS INC (FOLD), sold 10,648 shares at $11.51 ($123K) on 2015-03-20, disclosed to the SEC on 2015-03-24.
Scheduled sale ($123k) by VP, Patient Advocacy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2014-08-29 | $35K | — | Filing → |
| FOLD | BUY | 2014-08-29 | $35K | — | Filing → |
| FOLD | SELL | 2014-08-26 | $30K | — | Filing → |